Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 13-Sep-24 4:15 PM View:  | Verona Pharma Plc (VRNA) | 11-Sep-24 | Sale (Planned) | 600,000 | $3.76 | $2,254,080.00 | (4%) 14.94M to 14.34M | |
| 14-Aug-24 4:15 PM View: | Verona Pharma Plc (VRNA) | 13-Aug-24 | Sale (Planned) | 398,400 | $3.20 | $1,275,540.00 | (3%) 15.34M to 14.94M | |
| 14-Aug-24 4:15 PM View: | Verona Pharma Plc (VRNA) | 12-Aug-24 | Sale (Planned) | 1,600 | $3.13 | $5,008.00 | (< 1%) 15.34M to 15.34M | |
| 09-Aug-24 7:11 PM View: | Verona Pharma Plc (VRNA) | 07-Aug-24 | Grant | 800,000 | -- | -- | 5% 14.85M to 15.65M | |
| 09-Aug-24 7:11 PM View: | Verona Pharma Plc (VRNA) | 07-Aug-24 | Payment of Exercise | 314,800 | $2.62 | $824,776.00 | (2%) 15.65M to 15.34M | |
| 03-May-24 7:23 PM View: | Verona Pharma Plc (VRNA) | 01-May-24 | Payment of Exercise | 88,544 | $1.93 | $171,005.00 | (< 1%) 15.03M to 14.94M | |
| 05-Feb-24 6:09 PM View: | Verona Pharma Plc (VRNA) | 01-Feb-24 | Payment of Exercise | 480,664 | $2.29 | $1,102,550.00 | (3%) 15.51M to 15.03M | |
| 03-Nov-23 8:08 PM View: | Verona Pharma Plc (VRNA) | 01-Nov-23 | Payment of Exercise | 809,008 | $1.74 | $1,410,750.00 | (5%) 16.32M to 15.51M | |
| 24-Oct-23 4:05 PM View: | Verona Pharma Plc (VRNA) | 20-Oct-23 | Grant | 800,000 | -- | -- | 5% 15.52M to 16.32M | |
| 07-Aug-23 9:17 PM View: | Verona Pharma Plc (VRNA) | 07-Aug-23 | Sale (Planned) | 8,616 | $2.47 | $21,263.40 | (< 1%) 15.53M to 15.52M | |
| 07-Aug-23 9:17 PM View: | Verona Pharma Plc (VRNA) | 04-Aug-23 | Sale (Planned) | 150,000 | $2.50 | $374,880.00 | (< 1%) 15.68M to 15.53M | |
| 07-Aug-23 9:17 PM View: | Verona Pharma Plc (VRNA) | 03-Aug-23 | Sale (Planned) | 117,272 | $2.54 | $297,754.00 | (< 1%) 15.8M to 15.68M | |
| 03-Aug-23 8:31 PM View: | Verona Pharma Plc (VRNA) | 02-Aug-23 | Sale (Planned) | 73,704 | $2.59 | $191,114.00 | (< 1%) 15.87M to 15.8M | |
| 03-Aug-23 8:31 PM View: | Verona Pharma Plc (VRNA) | 01-Aug-23 | Sale (Planned) | 105,944 | $2.68 | $283,824.00 | (< 1%) 15.98M to 15.87M | |
| 03-May-23 10:00 PM View: | Verona Pharma Plc (VRNA) | 01-May-23 | Sale (Planned) | 455,528 | $2.58 | $1,173,390.00 | (3%) 16.43M to 15.98M | |
| 03-Feb-23 6:19 PM View: | Verona Pharma Plc (VRNA) | 01-Feb-23 | Sale (Planned) | 413,168 | $2.56 | $1,056,550.00 | (2%) 16.85M to 16.43M | |
| 21-Dec-22 4:05 PM View: | Verona Pharma Plc (VRNA) | 20-Dec-22 | Sale (Planned) | 600,000 | $2.12 | $1,269,060.00 | (3%) 17.45M to 16.85M | |
| 03-Nov-22 4:05 PM View: | Verona Pharma Plc (VRNA) | 01-Nov-22 | Payment of Exercise | 454,856 | $1.60 | $727,770.00 | (3%) 17.91M to 17.46M | |
| 03-Nov-22 4:05 PM View: | Verona Pharma Plc (VRNA) | 01-Nov-22 | Sale (Planned) | 13,160 | $1.67 | $22,011.40 | (< 1%) 17.46M to 17.45M | |
| 28-Sep-22 4:06 PM View: | Verona Pharma Plc (VRNA) | 26-Sep-22 | Grant | 3,600,000 | -- | -- | 25% 14.31M to 17.91M | |
| 11-Aug-22 9:45 PM View: | Verona Pharma Plc (VRNA) | 09-Aug-22 | Sale (Planned) | 600,000 | $1.75 | $1,050,000.00 | (4%) 14.91M to 14.31M | |
| 03-Aug-22 4:10 PM View: | Verona Pharma Plc (VRNA) | 01-Aug-22 | Payment of Exercise | 454,856 | $0.67 | $305,891.00 | (3%) 15.38M to 14.93M | |
| 03-Aug-22 4:10 PM View: | Verona Pharma Plc (VRNA) | 01-Aug-22 | Sale (Planned) | 13,168 | $0.70 | $9,214.97 | (< 1%) 14.93M to 14.91M | |
| 05-May-22 7:18 PM View: | Verona Pharma Plc (VRNA) | 03-May-22 | Sale (Planned) | 12,512 | $0.50 | $6,200.95 | (< 1%) 15.39M to 15.38M | |
| 03-May-22 8:18 PM View: | Verona Pharma Plc (VRNA) | 01-May-22 | Payment of Exercise | 432,128 | $0.52 | $225,787.00 | (3%) 15.83M to 15.39M | |
| 03-Feb-22 5:54 PM View: | Verona Pharma Plc (VRNA) | 02-Feb-22 | Sale (Planned) | 10,416 | $0.76 | $7,876.58 | (< 1%) 15.84M to 15.83M | |
| 03-Feb-22 5:54 PM View: | Verona Pharma Plc (VRNA) | 01-Feb-22 | Grant | 133,776 | $0.75 | $99,997.60 | < 1% 15.99M to 16.12M | |
| 03-Feb-22 5:54 PM View: | Verona Pharma Plc (VRNA) | 01-Feb-22 | Payment of Exercise | 288,320 | $0.78 | $223,794.00 | (2%) 16.12M to 15.84M | |
| 03-Nov-21 7:51 PM View: | Verona Pharma Plc (VRNA) | 02-Nov-21 | Sale (Planned) | 10,416 | $0.65 | $6,721.44 | (< 1%) 16.0M to 15.99M | |
| 03-Nov-21 7:51 PM View: | Verona Pharma Plc (VRNA) | 01-Nov-21 | Payment of Exercise | 454,848 | $0.64 | $291,103.00 | (3%) 16.46M to 16.0M | |
| 03-Aug-21 9:45 PM View: | Verona Pharma Plc (VRNA) | 02-Aug-21 | Sale (Planned) | 10,416 | $0.77 | $7,989.07 | (< 1%) 16.47M to 16.46M | |
| 03-Aug-21 9:45 PM View: | Verona Pharma Plc (VRNA) | 01-Aug-21 | Payment of Exercise | 454,840 | $0.79 | $357,049.00 | (3%) 16.92M to 16.47M | |
| 05-May-21 4:06 PM View: | Verona Pharma Plc (VRNA) | 03-May-21 | Payment of Exercise | 2,122,450 | $0.89 | $1,883,670.00 | (11%) 19.05M to 16.93M | |
| 05-May-21 4:06 PM View: | Verona Pharma Plc (VRNA) | 03-May-21 | Sale (Planned) | 10,416 | $0.87 | $9,094.21 | (< 1%) 16.93M to 16.92M | |
| 03-Mar-21 8:05 PM View: | Verona Pharma Plc (VRNA) | 01-Mar-21 | Sale (Planned) | 26,728 | $1.14 | $30,571.50 | (< 1%) 19.08M to 19.05M | |
| 01-Feb-21 8:53 PM View: | Verona Pharma Plc (VRNA) | 28-Jan-21 | Grant | 105,824 | -- | -- | < 1% 18.98M to 19.08M | |
| 12-Nov-19 4:34 PM View: | Dova Pharmaceuticals Inc. (DOVA) | 12-Nov-19 | Disposition | 9,024 | -- | -- | (100%) 9.02K to 0 | |
| 02-Oct-19 4:20 PM View: | Dova Pharmaceuticals Inc. (DOVA) | 30-Sep-19 | Private Sale (Planned) | 775 | $28.00 | $21,700.00 | (8%) 9.8K to 9.02K | |
| 02-Jul-19 4:59 PM View: | Dova Pharmaceuticals Inc. (DOVA) | 01-Jul-19 | Private Sale (Planned) | 1,545 | $14.17 | $21,892.70 | (14%) 11.34K to 9.8K | |
| 08-Jan-19 4:59 PM View: | Dova Pharmaceuticals Inc. (DOVA) | 04-Jan-19 | Grant | 8,844 | -- | -- | 354% 2.5K to 11.34K | |
| 21-Dec-18 5:05 PM View: | Dova Pharmaceuticals Inc. (DOVA) | 19-Dec-18 | Market Purchase | 2,500 | $6.28 | $15,700.00 | 100% 0 to 2.5K | 26% |